Your session is about to expire
← Back to Search
Ketogenic diet for Schizophrenia
Study Summary
This trial is studying whether a ketogenic diet can improve cognitive function in people with schizophrenia by improving neural network instability.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research project accept individuals aged 40 and above?
"Eligible participants for this clinical trial must be aged 18 or above and no older than 65."
Is participation in this research experiment open to me?
"This medical trial is searching for 70 volunteers, aged 18 to 65 and diagnosed with either schizophrenia or schizoaffective disorder (stable on antipsychotics) or bipolar disorder. The prerequisites are: fluency in English, access to the internet, readiness to follow a KETO diet over 4 weeks as well as willingness and ability to heat up meals accordingly."
How many participants are enrolled in this research project?
"Affirmative. Clinicaltrials.gov hosts the details of this clinical trial which was initially posted on April 21, 2022 and most recently updated on September 28th that same year. The research requires 70 participants from a single medical centre to be recruited for it's duration."
Are there opportunities for volunteers to partake in this experiment?
"Affirmative. The information available on clinicaltrials.gov attests to this trial's active recruitment status, which began in April 21st 2022 and was last updated at the end of September that same year. 70 participants are needed from a single location."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger